Is glucose‐induced hypersecretion of glicentin after the revision surgery using Roux‐en‐Y gastric bypass related to improved glycemic control due to insulin hypersecretion in a type 2 diabetes patient without diabetes remission after laparoscopic sleeve gastrectomy?
Journal of Diabetes Investigation · 2025
DOI: 10.1111/jdi.14325 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Yukako Yamamoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Endocrinology, Omi Medical Center, Kusatsu, Shiga, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Gastric Bypass, Gastrectomy, Insulin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
We report case details of a morbidly obese patient with type 2 diabetes mellitus (T2DM) who became a failure of diabetes remission after laparoscopic sleeve gastrectomy (LSG). He had a marked improvement of hyperglycemia after the revision surgery using Roux‐en‐Y gastric bypass (RYGB), where passage failure of a solid food intake at the gastric angle portion disappeared after the revision surgery. Interestingly, he showed improvements of insulin and a marked glicentin secretions with minor changes in glucagon related peptide 1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP) secretions in the oral glucose tolerance test OGTT after the RYGB surgery compared with post‐LSG. Although a marked increase in glucose‐induced glicentin secretion after RYGB surgery with increased insulin secretion, further studies are needed to confirm if the increased glicentin secretion after RYGB surgery is linked to stimulation of insulin secretion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diabetes and Endocrinology, Omi Medical Center, Kusatsu, Shiga, Japan.
- Department of Bariatric and Metabolic Surgery, Omi Medical Center, Kusatsu, Shiga, Japan.
- Metabolic Signal Research Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma, Japan.
ORCID-Profile: Tadahiro Kitamura, Masanori Iwanishi, Atsunori Kashiwagi
Zitieren
APA
Yamamoto, Y., Sekine, O., Ito-Kobayashi, J., Nishida, A., Togawa, T., Ozamoto, Y., Oe, Y., Hagiwara, A., Kobayashi, M., Kitamura, T., Iwanishi, M., Shimatsu, A., & Kashiwagi, A. (2025). Is glucose‐induced hypersecretion of glicentin after the revision surgery using Roux‐en‐Y gastric bypass related to improved glycemic control due to insulin hypersecretion in a type 2 diabetes patient without diabetes remission after laparoscopic sleeve gastrectomy?. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14325
Vancouver
Yamamoto Y, Sekine O, Ito-Kobayashi J, Nishida A, Togawa T, Ozamoto Y, et al. Is glucose‐induced hypersecretion of glicentin after the revision surgery using Roux‐en‐Y gastric bypass related to improved glycemic control due to insulin hypersecretion in a type 2 diabetes patient without diabetes remission after laparoscopic sleeve gastrectomy?. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.14325
BibTeX
@article{Yamamoto2025,
author = {Yamamoto, Yukako and Sekine, Osamu and Ito-Kobayashi, Jun and Nishida, Ayane and Togawa, Takeshi and Ozamoto, Yuki and Oe, Yasumitsu and Hagiwara, Akeo and Kobayashi, Masaki and Kitamura, Tadahiro and Iwanishi, Masanori and Shimatsu, Akira and Kashiwagi, Atsunori},
title = {Is glucose‐induced hypersecretion of glicentin after the revision surgery using Roux‐en‐Y gastric bypass related to improved glycemic control due to insulin hypersecretion in a type 2 diabetes patient without diabetes remission after laparoscopic sleeve gastrectomy?},
journal = {Journal of Diabetes Investigation},
year = {2025},
doi = {10.1111/jdi.14325}
}
EUVIMED